{
    "Trade/Device Name(s)": [
        "GSP Neonatal GALT kit"
    ],
    "Submitter Information": "Wallac Oy, Division of PerkinElmer Inc.",
    "510(k) Number": "K100101",
    "Predicate Device Reference 510(k) Number(s)": [
        "K950803"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KQP"
    ],
    "Summary Letter Date": "April 28, 2010",
    "Summary Letter Received Date": "April 30, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1315"
    ],
    "Regulation Name(s)": [
        "Galactose-1-phosphate uridyl transferase test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Galactose-1-phosphate uridyl transferase (GALT)"
    ],
    "Specimen Type(s)": [
        "Blood specimens dried on filter paper",
        "Dried blood spots"
    ],
    "Specimen Container(s)": [
        "Filter paper cassettes (Whatman no. 903)"
    ],
    "Instrument(s)/Platform(s)": [
        "GSP instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Quantitative enzymatic assay",
        "Prompt fluorescence"
    ],
    "Methodologies": [
        "Enzymatic activity measurement",
        "Fluorescence detection"
    ],
    "Submission Type(s)": [
        "Kit",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for GSP Neonatal GALT kit for quantitative enzymatic determination of GALT activity in newborn dried blood spot specimens.",
    "Indications for Use Summary": "Intended for the quantitative determination of galactose-1-phosphate uridyl transferase activity in dried blood spot specimens as an aid in screening newborns for classical galactosemia using the GSP instrument.",
    "fda_folder": "Clinical Chemistry"
}